Talecris Biotherapeutics Holdings Corp.Research Triangle Park, NC, United States (NASDAQ (GS): TLCR)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Talecris Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 08 Dec 07 Dec 06
Revenue 1,374.3 1,218.5 1,114.5
Cost of Goods Sold 882.2 -- 684.8
Gross Profit 492.1 -- 429.7
Gross Profit Margin 35.8% 0.0% 38.6%
SG&A Expense 227.5 -- 308.2
Depreciation & Amortization 20.3 -- --
Operating Income 199.4 -- 135.7
Operating Margin 14.5% -- 12.2%
Nonoperating Income 0.8 -- 0.7
Nonoperating Expenses (97.0) -- 49.8
Income Before Taxes 102.4 -- 86.6
Income Taxes 36.6 -- 2.2
Net Income After Taxes 65.8 0.0 84.4

Continuing Operations 65.8 -- 84.4
Discontinued Operations -- -- 0.0
Total Operations 65.8 -- 84.4
Total Net Income 65.8 123.6 87.4
Net Profit Margin 4.8% 10.1% 7.8%

Diluted EPS from Total Net Income ($) -- -- --
Dividends per Share 0.00 -- --
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy